Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
441
datasets available to search
ShareScore release 0.9.0
Dataset results
441 results for “Amyloidosis”
A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis
ClinicalTrials.gov study NCT02603172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis
ClinicalTrials.gov study NCT00458822. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.
ClinicalTrials.gov study NCT05560555. IPD Sharing: NO. Countries: 1. Publications: 0.
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov study NCT00477971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
ClinicalTrials.gov study NCT02632786. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
ClinicalTrials.gov study NCT00520767. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease
ClinicalTrials.gov study NCT03098901. IPD Sharing: NO. Countries: 0. Publications: 9.
Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
ClinicalTrials.gov study NCT01078454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
ClinicalTrials.gov study NCT00064337. IPD Sharing: Not stated. Countries: 1. Publications: 0.
2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis
ClinicalTrials.gov study NCT00075608. IPD Sharing: NO. Countries: 1. Publications: 0.
A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis
ClinicalTrials.gov study NCT02292186. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis
ClinicalTrials.gov study NCT04760171. IPD Sharing: NO. Countries: 0. Publications: 4.
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
ClinicalTrials.gov study NCT04659798. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)
ClinicalTrials.gov study NCT05839626. IPD Sharing: YES. Countries: 7. Publications: 0.
A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
ClinicalTrials.gov study NCT02545907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis
ClinicalTrials.gov study NCT02590588. IPD Sharing: NO. Countries: 1. Publications: 0.
The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant
ClinicalTrials.gov study NCT02595983. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis
ClinicalTrials.gov study NCT04304144. IPD Sharing: YES. Countries: 1. Publications: 0.
Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis
ClinicalTrials.gov study NCT01072773. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors
ClinicalTrials.gov study NCT04421040. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.